Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1 Receptor Pathways in the Diet-Induced Obese Rat

Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats

(2008) Brenda M. Geiger et al.   FASEB JOURNAL

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

(2008) Arne Astrup et al.   LANCET

Bromocriptine Administration Reduces Hyperphagia and Adiposity and Differentially Affects Dopamine D2 Receptor and Transporter Binding in Leptin-Receptor-Deficient Zucker Rats and Rats with Diet-Induced Obesity

(2008) Lisa M. Davis et al.   NEUROENDOCRINOLOGY

Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease

(2008) Arne Astrup et al.   Obesity

Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration

(2008) Jean D Deupree et al.   BMC Pharmacology & Toxicology

Contribution of the active metabolite M1 to the pharmacological activity of tesofensinein vivo: a pharmacokinetic-pharmacodynamic modelling approach

(2007) T Lehr et al.   BRITISH JOURNAL OF PHARMACOLOGY